Juno Therapeutics raises $120 million in Series A funding - MarketLine Financial Deals

Juno Therapeutics raises $120 million in Series A funding

Juno Therapeutics raises $120 million in Series A funding - MarketLine Financial Deals
Juno Therapeutics raises $120 million in Series A funding
Published Dec 04, 2013
2 pages — Published Dec 04, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Juno Therapeutics, Inc., a US-based biotechnology company focused on developing immune therapies for cancer, has secured $120 million in Series A funding

  
Source:
Document ID
MA143573_131206
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Juno Therapeutics raises $120 million in Series A funding" Dec 04, 2013. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Juno-Therapeutics-raises-120-million-in-Series-A-funding-2052-99229>
  
APA:
MarketLine Financial Deals. (2013). Juno Therapeutics raises $120 million in Series A funding Dec 04, 2013. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Juno-Therapeutics-raises-120-million-in-Series-A-funding-2052-99229>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.